Drugs Made In America Acquisition II Corp.
DMIIR- Exchange
- Nasdaq
- Industry
- Blank Checks
- SEC CIK
- 0002040475
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2025 | Sep 26, 2025 | Stockwell LynnCEO and Exe. Chair of Board | PPurchaseOrdinary shares | +700K | – | – | 15.08M | +4.9% | SEC |
| Oct 1, 2025 | Sep 26, 2025 | Stockwell LynnCEO and Exe. Chair of Board | SSaleOrdinary shares | −7.97M | – | – | 6.71M | −54.3% | SEC |
| Oct 1, 2025 | Sep 26, 2025 | Stockwell LynnCEO and Exe. Chair of Board | PPurchaseOrdinary shares · Derivative | +70K | – | – | 700K | – | SEC |
| Oct 1, 2025 | Sep 26, 2025 | Drugs Made In America Acquisition II LLC10% Owner | PPurchaseOrdinary shares | +700K | – | – | 15.08M | +4.9% | SEC |
| Oct 1, 2025 | Sep 26, 2025 | Drugs Made In America Acquisition II LLC10% Owner | SSaleOrdinary shares | −7.97M | – | – | 6.71M | −54.3% | SEC |
| Oct 1, 2025 | Sep 26, 2025 | Drugs Made In America Acquisition II LLC10% Owner | PPurchaseOrdinary shares · Derivative | +700K | – | – | 700K | – | SEC |